Suppression of A-to-I RNA-editing enzyme ADAR1 sensitizes hepatocellular carcinoma cells to oxidative stress through regulating Keap1/Nrf2 pathway

Abstract Background A-to-I RNA editing is an abundant post-transcriptional modification event in hepatocellular carcinoma (HCC). Evidence suggests that adenosine deaminases acting on RNA 1 (ADAR1) correlates to oxidative stress that is a crucial factor of HCC pathogenesis. The present study investig...

Full description

Bibliographic Details
Main Authors: Houhong Wang, Xiaoyu Wei, Lu Liu, Junfeng Zhang, Heng Li
Format: Article
Language:English
Published: BMC 2024-03-01
Series:Experimental Hematology & Oncology
Subjects:
Online Access:https://doi.org/10.1186/s40164-024-00494-7
_version_ 1797259414411935744
author Houhong Wang
Xiaoyu Wei
Lu Liu
Junfeng Zhang
Heng Li
author_facet Houhong Wang
Xiaoyu Wei
Lu Liu
Junfeng Zhang
Heng Li
author_sort Houhong Wang
collection DOAJ
description Abstract Background A-to-I RNA editing is an abundant post-transcriptional modification event in hepatocellular carcinoma (HCC). Evidence suggests that adenosine deaminases acting on RNA 1 (ADAR1) correlates to oxidative stress that is a crucial factor of HCC pathogenesis. The present study investigated the effect of ADAR1 on survival and oxidative stress of HCC, and underlying mechanisms. Methods ADAR1 expression was measured in fifty HCC and normal tissues via real-time quantitative PCR, and immunohistochemistry. For stable knockdown or overexpression of ADAR1, adeno-associated virus vectors carrying sh-ADAR1 or ADAR1 overexpression were transfected into HepG2 and SMMC-7721 cells. Transfected cells were exposed to oxidative stress agonist tBHP or sorafenib Bay 43-9006. Cell proliferation, apoptosis, and oxidative stress were measured, and tumor xenograft experiment was implemented. Results ADAR1 was up-regulated in HCC and correlated to unfavorable clinical outcomes. ADAR1 deficiency attenuated proliferation of HCC cells and tumor growth and enhanced apoptosis. Moreover, its loss facilitated intracellular ROS accumulation, and elevated Keap1 and lowered Nrf2 expression. Intracellular GSH content and SOD activity were decreased and MDA content was increased in the absence of ADAR1. The opposite results were observed when ADAR1 was overexpressed. The effects of tBHP and Bay 43–9006 on survival, apoptosis, intracellular ROS accumulation, and Keap1/Nrf2 pathway were further exacerbated by simultaneous inhibition of ADAR1. Conclusions The current study unveils that ADAR1 is required for survival and oxidative stress of HCC cells, and targeting ADAR1 may sensitize HCC cells to oxidative stress via modulating Keap1/Nrf2 pathway.
first_indexed 2024-04-24T23:09:03Z
format Article
id doaj.art-3f2453feeb1140d38db502d5f23e2475
institution Directory Open Access Journal
issn 2162-3619
language English
last_indexed 2024-04-24T23:09:03Z
publishDate 2024-03-01
publisher BMC
record_format Article
series Experimental Hematology & Oncology
spelling doaj.art-3f2453feeb1140d38db502d5f23e24752024-03-17T12:17:51ZengBMCExperimental Hematology & Oncology2162-36192024-03-0113112010.1186/s40164-024-00494-7Suppression of A-to-I RNA-editing enzyme ADAR1 sensitizes hepatocellular carcinoma cells to oxidative stress through regulating Keap1/Nrf2 pathwayHouhong Wang0Xiaoyu Wei1Lu Liu2Junfeng Zhang3Heng Li4Department of General Surgery, The First Hospital Affiliated to Fuyang Normal UniversityDepartment of Infectious Diseases, Yongchuan Hospital of Chongqing Medical UniversityDepartment of Endocrinology, The Affiliated Nantong Hospital of Shanghai Jiao Tong UniversityDepartment of Radiology, General Hospital of Western Theater Command of PLADepartment of Comprehensive Surgery, Anhui Provincial Cancer Hospital, West District of The First Affiliated Hospital of USTCAbstract Background A-to-I RNA editing is an abundant post-transcriptional modification event in hepatocellular carcinoma (HCC). Evidence suggests that adenosine deaminases acting on RNA 1 (ADAR1) correlates to oxidative stress that is a crucial factor of HCC pathogenesis. The present study investigated the effect of ADAR1 on survival and oxidative stress of HCC, and underlying mechanisms. Methods ADAR1 expression was measured in fifty HCC and normal tissues via real-time quantitative PCR, and immunohistochemistry. For stable knockdown or overexpression of ADAR1, adeno-associated virus vectors carrying sh-ADAR1 or ADAR1 overexpression were transfected into HepG2 and SMMC-7721 cells. Transfected cells were exposed to oxidative stress agonist tBHP or sorafenib Bay 43-9006. Cell proliferation, apoptosis, and oxidative stress were measured, and tumor xenograft experiment was implemented. Results ADAR1 was up-regulated in HCC and correlated to unfavorable clinical outcomes. ADAR1 deficiency attenuated proliferation of HCC cells and tumor growth and enhanced apoptosis. Moreover, its loss facilitated intracellular ROS accumulation, and elevated Keap1 and lowered Nrf2 expression. Intracellular GSH content and SOD activity were decreased and MDA content was increased in the absence of ADAR1. The opposite results were observed when ADAR1 was overexpressed. The effects of tBHP and Bay 43–9006 on survival, apoptosis, intracellular ROS accumulation, and Keap1/Nrf2 pathway were further exacerbated by simultaneous inhibition of ADAR1. Conclusions The current study unveils that ADAR1 is required for survival and oxidative stress of HCC cells, and targeting ADAR1 may sensitize HCC cells to oxidative stress via modulating Keap1/Nrf2 pathway.https://doi.org/10.1186/s40164-024-00494-7ADAR1Hepatocellular carcinomaOxidative stressSurvivalKeap1/Nrf2Reactive oxygen species
spellingShingle Houhong Wang
Xiaoyu Wei
Lu Liu
Junfeng Zhang
Heng Li
Suppression of A-to-I RNA-editing enzyme ADAR1 sensitizes hepatocellular carcinoma cells to oxidative stress through regulating Keap1/Nrf2 pathway
Experimental Hematology & Oncology
ADAR1
Hepatocellular carcinoma
Oxidative stress
Survival
Keap1/Nrf2
Reactive oxygen species
title Suppression of A-to-I RNA-editing enzyme ADAR1 sensitizes hepatocellular carcinoma cells to oxidative stress through regulating Keap1/Nrf2 pathway
title_full Suppression of A-to-I RNA-editing enzyme ADAR1 sensitizes hepatocellular carcinoma cells to oxidative stress through regulating Keap1/Nrf2 pathway
title_fullStr Suppression of A-to-I RNA-editing enzyme ADAR1 sensitizes hepatocellular carcinoma cells to oxidative stress through regulating Keap1/Nrf2 pathway
title_full_unstemmed Suppression of A-to-I RNA-editing enzyme ADAR1 sensitizes hepatocellular carcinoma cells to oxidative stress through regulating Keap1/Nrf2 pathway
title_short Suppression of A-to-I RNA-editing enzyme ADAR1 sensitizes hepatocellular carcinoma cells to oxidative stress through regulating Keap1/Nrf2 pathway
title_sort suppression of a to i rna editing enzyme adar1 sensitizes hepatocellular carcinoma cells to oxidative stress through regulating keap1 nrf2 pathway
topic ADAR1
Hepatocellular carcinoma
Oxidative stress
Survival
Keap1/Nrf2
Reactive oxygen species
url https://doi.org/10.1186/s40164-024-00494-7
work_keys_str_mv AT houhongwang suppressionofatoirnaeditingenzymeadar1sensitizeshepatocellularcarcinomacellstooxidativestressthroughregulatingkeap1nrf2pathway
AT xiaoyuwei suppressionofatoirnaeditingenzymeadar1sensitizeshepatocellularcarcinomacellstooxidativestressthroughregulatingkeap1nrf2pathway
AT luliu suppressionofatoirnaeditingenzymeadar1sensitizeshepatocellularcarcinomacellstooxidativestressthroughregulatingkeap1nrf2pathway
AT junfengzhang suppressionofatoirnaeditingenzymeadar1sensitizeshepatocellularcarcinomacellstooxidativestressthroughregulatingkeap1nrf2pathway
AT hengli suppressionofatoirnaeditingenzymeadar1sensitizeshepatocellularcarcinomacellstooxidativestressthroughregulatingkeap1nrf2pathway